Articles published in Journal of Biomedical Sciences have been cited by esteemed scholars and scientists all around the world. Journal of Biomedical Sciences has got h-index 18, which means every article in Journal of Biomedical Sciences has got 18 average citations.
Following are the list of articles that have cited the articles published in Journal of Biomedical Sciences.
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total published articles |
37 | 65 | 37 | 23 |
Conference proceedings |
0 | 0 | 0 | 20 |
Citations received as per Google Scholar, other indexing platforms and portals |
268 | 216 | 188 | 126 |
Journal total citations count | 1283 |
Journal impact factor | 4.78 |
Journal 5 years impact factor | 5.16 |
Journal cite score | 4.95 |
Journal h-index | 18 |
Journal Impact Factor 2020 formula |
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
Journal 5-year Impact Factor 2020 formula |
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
Journal CiteScore |
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
Synthesis and Stereochemical Assignment of Conioidine A: DNAand HSA-Binding Studies of the Four Diastereomers |
|
Apixaban and rivaroxaban in patients with cerebral venous thrombosis. |
|
Warfarin replaces dexamethasone in drug complexes with human serum albumin - a fluorescence spectroscopy study |
|
Study of Interaction of some Benzodiazepines with Human Serum Albumin by Fluorescent Method |
|
A dual alkylated peptide-ligand enhances affinity to human serum albumin |
|
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review |
|
Association models for binding of molecules to nanostructures |
|
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol |
|
Rivaroxaban for the treatment of cerebral venous thrombosis |
|
The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis. |
|
Apixaban for the treatment of cerebral venous thrombosis: A case series. |
|
Novel Factor Xa Inhibitor for the Treatment of Cerebral Venous and Sinus Thrombosis First Experience in 7 Patients |
|
Treatment of unusual thrombotic manifestations |
|
Management of Venous Sinus Thrombosis. |
|
Direct oral anticoagulant use in patients with thrombophilia, antiphospholipid syndrome or venous thrombosis of unusual sites: A narrative review |
|
New Oral Anticoagulants versus Warfarin for Cerebral Venous Thrombosis: A Multi-Center, Observational Study |
|
Implikasi Polimorfisme Gen CYP2A6 terhadap Penyakit Kardiovaskular |
|
Implikasi Polimorfsme Gen CYP2A6 terhadap Penyakit Kardiovaskular |
|
AKUT M?YOKARD ?NFARKTÜSÜ GEÇ?REN B?REYLER?N BESLENME DURUMU ?LE SERUM NESFAT?N-1 DÜZEY? ARASINDAK? ?L??K?N?N DE?ERLEND?R?LMES? |
|
Spectroscopic Characterization of the Interaction between Dopamine and Human Serum Albumin |
|